CONTACT SUBSCRIBE

Ben
Lehman

IP Strategist

Seattle, Washington, US

I love travelling to the Northern hemisphere. When the days in Australia are starting to get longer and the nights colder, the other side of the world is just starting to emerge from the cold. It's a great contrast (and good fun packing a t-shirt in the middle of winter).

photo credit: B Mully

back to scorecards index

Browse Scorecards

Click here to receive Global IP Scorecards™ by email

IP Scorecards

Fosamax (Alendronic Acid)

Contribute to this scorecard

Alendronic acid or alendronate sodium (sold as Fosamax by Merck) is a bisphosphonate drug used for osteoporosis and several other bone diseases.  It is marketed alone as well as in combination with vitamin D (2,800 U and 5600 U, under the name Fosamax+D).

 

Copyright Tuesday, December 2, 2008 Duncan Bucknell

view more background information on this scorecard

Updates by Country

   (Click on a country name to view)